Effectiveness and Safety of Antiemetic Aprepitant in Japanese Patients Receiving High-Dose Chemotherapy Prior to Autologous Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Effectiveness and Safety of Antiemetic Aprepitant in Japanese Patients Receiving High-Dose Chemotherapy Prior to Autologous Hematopoietic Stem Cell Transplantation

Published:2013 Issue:5 Volume:36 Page:819-824
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Uchida Mayako¹,Ikesue Hiroaki¹,Miyamoto Toshihiro²,Kato Koji²,Suetsugu Kimitaka¹,Ichinose Kimiko³,Hiraiwa Hiromi³,Sakurai Asako³,Takenaka Katsuto²,Muta Tsuyoshi²,Iwasaki Hiromi⁴,Teshima Takanori⁴,Shiratsuchi Motoaki⁵,Egashira Nobuaki¹,Akashi Koichi²,Oishi Ryozo¹

Affiliation:

1. Department of Pharmacy, Kyushu University Hospital

2. Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

3. Unit for Cell Therapy and Transplantation, Kyushu University Hospital

4. Center for Cellular and Molecular Medicine, Kyushu University Hospital

5. Department of Medicine and Bioregulatory Science, Kyushu University Graduate School of Medical Sciences

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/36/5/36_b12-01012/_pdf

Reference30 articles.

1. 1) Hesketh PJ. Chemotherapy-induced nausea and vomiting. N. Engl. J. Med., 358, 2482–2494 (2008).

2. 2) Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, ESMO/MASCC Guidelines Working Group. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann. Oncol., 21 (Suppl. 5), v232–v243 (2010).

3. 3) National Comprehensive Cancer Network (NCCN). “NCCN Clinical Practice Guidelines in Oncology. Antiemesis. V.1.2012.”: ‹http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf›, cited 9 October, 2012.

4. 4) Einhorn LH, Grunberg SM, Rapoport B, Rittenberg C, Feyer P. Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement. Support. Care Cancer, 19 (Suppl. 1), S1–S4 (2011).

5. 5) Abbott B, Ippoliti C, Hecth D, Bruton J, Whaley B, Champlin R. Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation. Bone Marrow Transplant., 25, 1279–1283 (2000).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation;Clinical Hematology International;2022-07-11

2. Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience;Supportive Care in Cancer;2021-08-04

3. Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs;Annals of Hematology;2020-02-08

4. Clinical Pharmacology Research for Promoting Individualized Cancer Chemotherapy;YAKUGAKU ZASSHI;2019-06-01

5. Chemotherapy Induced Nausea and Vomiting;International Manual of Oncology Practice;2019